Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hyperandrogenism
Phenotype C0032460|polycystic ovaries
Sentences 3
PubMedID- 21577021 Presence of oligo- and/or anovulation (anov) and hyperandrogenemia and/or hyperandrogenism (ha) with or without polycystic ovaries (pco)) appear to have a more adverse metabolic profile than patients diagnosed with the additional criteria introduced in 2003 (i.e.
PubMedID- 23226657 This possibly indicates that hyperinsulinemia is the primary factor involved in polycystic ovaries in patients with lipodystrophy, hyperandrogenism, and its peripheral manifestations ensue secondarily.
PubMedID- 21521255 All probands had pcos, defined by symptoms of anovulation and/or hyperandrogenism with polycystic ovaries on ultrasound.

Page: 1